Table 2. Clinical data of the probands with CORD and identified potential pathogenic mutations.
Family ID | Gene | Nucleotide changes | Sex | Age (year) at | First | Best visual acuity | Fundus changes | ERG responses from | ||||
exam | onset | symptom | right | left | right | left | rod | cone | ||||
Family 1 | ABCA4 | c.[1957C>T];[4604dup] | M | 7.0 | 6.0 | PV, PP | 0.20 | 0.15 | MA, TPOD, ARA | MA, TPOD, ARA | Normal | Reduced |
Family 2 | CNGB3 | c.[1774dup];[1774dup] | M | 6.5 | EC | PV,NYS | 0.20 | 0.20 | MA, TPOD | MA, TPOD | Mildly reduced | Extinguished |
Family 3 | CNGB3 | c.[129+1G>A];[129+1G>A] | F | 5.0 | 0.3 | PV,NYS, PP | 0.20 | 0.20 | MA, TPOD, ARA | MA, TPOD, ARA | Normal | Extinguished |
Family 4 | CNGB3 | c.[1957G>A];[2415A>C] | F | 4.5 | 0.5 | PP,NYS | 0.10 | 0.20 | ARA | ARA | Mildly reduced | Severely reduced |
Family 5 | PDE6C | c.[1935+1del];[2518+5G>C] | M | 7.0 | EC | NYS | 0.05 | 0.05 | High myopic | High myopic | Normal | Severely reduced |
Family 6 | PDE6C | c.[1004+1G>A];[1004+1G>A] | F | 2.0 | EC | PV,PP,NYS | PO | PO | NA | NA | Mildly reduced | Extinguished |
Family 7 | RPGRIP1 | c.[799C>T];[2592T>G] | M | 3.6 | FMB | PV, PP, NYS | NA | NA | ARA,CRD | ARA,CRD | Extinguished | Extinguished |
Family 8 | CACNA1F | c.[2542G>A]; [0] | M | 2.3 | NA | PP, NYS | NA | NA | MA | MA | Severely reduced* | Extinguished |
Family 9 | RPGR | c.[785C>G]; [0] | M | 28.0 | EC | PV, PP | 0.10 | 0.10 | MA, TPOD, ARA | MA, TPOD, ARA | Moderately reduced | Extinguished |
Family 10 | RPGR | c.[2447_2461del]; [0] | M | 9.0 | EC | PV, PP | 0.20 | 0.20 | MA | MA | Normal | Extinguished |
Note: F = female; M = male; EC = early childhood; FMB = first few months after birth; PV = poor vision; PP = photophobia; NYS = nystagmus; PO = pursuing object; NA = not available; MA = macular atrophy; TPOD = temporal pallor of optic disc; ARA = attenuated retinal arteries; CRD = carpet-like retinal degeneration.
This patient did not have the “electronegative” ERG in the standard combined response.